Does TORIPALIMAB Cause Erythema multiforme? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Erythema multiforme have been filed in association with TORIPALIMAB (LOQTORZI). This represents 0.4% of all adverse event reports for TORIPALIMAB.
5
Reports of Erythema multiforme with TORIPALIMAB
0.4%
of all TORIPALIMAB reports
0
Deaths
3
Hospitalizations
How Dangerous Is Erythema multiforme From TORIPALIMAB?
Of the 5 reports, 3 (60.0%) required hospitalization.
Is Erythema multiforme Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TORIPALIMAB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does TORIPALIMAB Cause?
Myelosuppression (590)
Off label use (276)
White blood cell count decreased (144)
Anaemia (67)
Hypothyroidism (67)
Neutrophil count decreased (67)
Nausea (60)
Rash (59)
Vomiting (58)
Platelet count decreased (53)
What Other Drugs Cause Erythema multiforme?
IBUPROFEN (226)
NIVOLUMAB (221)
PEMBROLIZUMAB (212)
LAMOTRIGINE (210)
ACETAMINOPHEN (172)
PACLITAXEL (166)
AMOXICILLIN (164)
ALLOPURINOL (147)
CARBOPLATIN (146)
CLARITHROMYCIN (131)
Which TORIPALIMAB Alternatives Have Lower Erythema multiforme Risk?
TORIPALIMAB vs TORSEMIDE
TORIPALIMAB vs TOVIAZ
TORIPALIMAB vs TOVORAFENIB
TORIPALIMAB vs TOZINAMERAN
TORIPALIMAB vs TRABECTEDIN